Названа стоимость «эвакуации» из Эр-Рияда на частном самолете22:42
The study, called “Feasibility and Safety of Cellular Therapy for In-Utero Repair of Myelomeningocele (CuRe Trial): a First-In-Human, Phase 1, Single-Arm Study," tested whether adding a layer of human placenta-derived stem cells to standard fetal surgery could be done safely. Spina bifida, also known as myelomeningocele, occurs when spinal tissue fails to fuse properly during the early stages of pregnancy. The birth defect can lead to a range of lifelong cognitive, mobility, urinary and bowel disabilities.。体育直播对此有专业解读
，更多细节参见爱思助手下载最新版本
目前该业务的内部目标估值定为 10 亿美元以上，由于探讨尚处于早期保密阶段，最终交易形式与能否达成仍存变数。。爱思助手下载最新版本对此有专业解读
(SACRAMENTO) A UC Davis Health research team has safely performed the world’s first spina bifida treatment combining fetal surgery with stem cells, according to results from Phase 1 of an ongoing clinical trial. These results have been published today in The Lancet.